SCHEMBL6178090

SCHEMBL6178090

CCC(N)C[C@H]1CCCN1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.44
CYP2D6 P10635 2/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 2/20 0.44
KMT2A Q03164 2/20 0.44
GHSR Q92847 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
TSHR P16473 1/20 0.44
MLNR O43193 1/20 0.44
ABCB11 O95342 1/20 0.44
EGFR P00533 1/20 0.44
FYN P06241 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
HTR1A P08908 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12810953 1.00 FDPS (0.44) FDPSCYP2D6MEN1LMNATP53
SCHEMBL20032027 0.94 CYP2D6 (0.52) FDPSCYP2D6MEN1LMNATP53
SCHEMBL22607232 0.85
SCHEMBL19220994 0.85 CYP2D6 (0.42) FDPSCYP2D6MEN1LMNATP53
SCHEMBL3586728 0.84 FDPS (0.44) FDPSCYP2D6MEN1LMNATP53
SCHEMBL15559415 0.82 CYP2D6 (0.46) FDPSCYP2D6MEN1LMNATP53
SCHEMBL23866017 0.81 CYP2D6 (0.42) FDPSCYP2D6MEN1LMNATP53
SCHEMBL20800996 0.79
SCHEMBL21964921 0.78 FDPS (0.46) FDPSCYP2D6MEN1LMNATP53
SCHEMBL8656127 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592389-A2 PIPERAZINE-2-CARBOXAMIDE DERIVATIVES Applied Research Systems ARS Holding N.V. (AN) 2005-11-09 EP disclosed
WO-2004071390-A2 PIPERAZINE-2-CARBOXAMIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2004-08-26 WO disclosed